Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
1.310
+0.040 (3.15%)
At close: Sep 18, 2026, 4:00 PM EDT
1.330
+0.020 (1.53%)
After-hours: Sep 18, 2026, 7:47 PM EDT
Celularity Market Cap
Celularity has a market cap or net worth of $37.92 million as of September 18, 2026. Its market cap has decreased by -33.92% in one year.
Market Cap
37.92M
Enterprise Value
106.46M
1-Year Change
-33.92%
Ranking
Category
Stock Price
$1.31
ChartMarket Cap Chart
Since August 8, 2019, Celularity's market cap has decreased from $352.19M to $37.92M, a decrease of -89.23%. That is a compound annual growth rate of -26.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 37.92M | 19.95% |
| Dec 31, 2025 | 31.61M | -32.41% |
| Dec 31, 2024 | 46.77M | -1.00% |
| Dec 29, 2023 | 47.24M | -74.75% |
| Dec 30, 2022 | 187.07M | -70.41% |
| Dec 31, 2021 | 632.14M | 59.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Metagenomi Therapeutics | 41.55M |
| Veru Inc. | 41.09M |
| Immutep | 39.81M |
| Seres Therapeutics | 39.77M |
| Lite Strategy | 38.45M |
| Actinium Pharmaceuticals | 38.36M |
| CervoMed | 36.74M |
| BriaCell Therapeutics | 36.70M |